Page last updated: 2024-11-08

bekanamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bekanamycin: kanendomycin is the sulfate of bekanamycin; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID439318
CHEMBL ID176
CHEBI ID28098
SCHEMBL ID158426
MeSH IDM0041714

Synonyms (76)

Synonym
CHEBI:28098 ,
o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1->4)-o-(2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1->6))-2-deoxy-d-streptamine
nebramycin v
2'-amino-2'-deoxykanamycin
(1r,2s,3s,4r,6s)-4,6-diamino-3-(3-amino-3-deoxy-alpha-d-glucopyranosyloxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-d-glucopyranoside
SDCCGMLS-0066707.P001
(1r,2s,3s,4r,6s)-4,6-diamino-3-[(3-amino-3-deoxy-alpha-d-glucopyranosyl)oxy]-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-d-glucopyranoside
klebcil
SPECTRUM_001112
SPECTRUM4_001831
ACON0_001346
MEGXM0_000486
NCGC00178790-01
D07497
bekanamycin (inn)
nk-1006
aminodeoxykanamycin
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(1r,2s,3s,4r,6s)-4,6-diamino-3-[(2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
nk 1006
BSPBIO_002158
9cs ,
C00825
kanamycin b
bekanamycin
nebramycin factor 5
NCGC00096063-01
KBIO2_004160
KBIOGR_002528
KBIOSS_001592
KBIO3_001658
KBIO2_006728
KBIO2_001592
SPBIO_000640
SPECTRUM2_000640
SPECTRUM3_000619
SPECTRUM5_000621
bekanamycine [inn-french]
becanamicina [inn-spanish]
einecs 225-170-5
bekanamycinum [inn-latin]
antibiotic derived from streptomyces kanamyceticus
bekanamycin [inn]
brn 0061646
antibiotic derived from streptomyces kanamyceticus. kanamycin b
d-streptamine, o-3-amino-3-deoxy-alpha-d-glucopyranosyl-(1-4)-o-(2,6-diamino-2,6-dideoxy-alpha-d-glucopyranosyl-(1-6))-2-deoxy-
CHEMBL176
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-[(1r,2s,3s,4r,6s)-4,6-diamino-3-[(2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4-diol
cas-4696-76-8
dtxsid8023185 ,
tox21_113194
dtxcid903185
becanamicina
bekanamycinum
bekanamycine
15jt14c3gi ,
unii-15jt14c3gi
bdbm50368267
(1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-.alpha.-d-glucopyranoside
.alpha.-d-glucopyranoside, (1r,2s,3s,4r,6s)-4,6-diamino-3-((3-amino-3-deoxy-.alpha.-d-glucopyranosyl)oxy)-2-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-
bekanamycin [who-dd]
kanamycin b [mi]
tobramycin impurity a [ep impurity]
SCHEMBL158426
CS-4772
kanamycin b, antibiotic for culture media use only
W-106082
HY-B1174
AB00053732_02
AKOS030526149
SBI-0052603.P002
kanamycin b; bekanamycin
Q3637540
(2r,3s,4r,5r,6r)-5-amino-2-(aminomethyl)-6-(((1r,2s,3s,4r,6s)-4,6-diamino-3-(((2s,3r,4s,5s,6r)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)tetrahydro-2h-pyran-3,4-diol
DB13673
A924196
gtpl12182

Research Excerpts

Actions

ExcerptReferenceRelevance
"Bekanamycin at a lower concentration than that needed to induce electrophysiological effects potentiated verapamil 1 x 10(-8) effects on cardiac pacemaker cells."( Effects of bekanamycin and dibekacin on the electrical activity of cardiac pacemaker cells.
Castrillon, JL; Hernandez, DA; Morales, MA, 1993
)
1.4

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" over a course of 5 days; dosage interval 12 h, dosage 2,5, 5, 10, 20, 100 and 500 mg/kg per day, respectively."( [Experimental study on renal tolerability of aminoglycosides butirosin and bekanamycin (author's transl)].
Beck, H; Eikenberg, P; Sack, K, 1980
)
0.49
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
kanamycins
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.08900.000229.305416,493.5996AID743069
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
3-oxoacyl-[acyl-carrier-protein] synthase 3 Escherichia coliIC50 (µMol)6.30002.10004.20006.3000AID1061844
Acyl-protein thioesterase 1Rattus norvegicus (Norway rat)IC50 (µMol)110.00000.05700.05700.0570AID102990
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (271)

Assay IDTitleYearJournalArticle
AID1123054Antibacterial activity against Pseudomonas aeruginosa 20610 expressing aminoglycoside-3'-phosphotransferase and aminoglycoside-3-acetyltransferase-1 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID372896Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID670730Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID1265787Antibacterial activity against methicillin-resistant Staphylococcus aureus by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1265781Resistance index, ratio of MIC for Listeria monocytogenes ATCC 19115 after 6-passage to MIC for Listeria monocytogenes ATCC 19115 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID65067Percent killing of the total Escherichia coli K12 (ATCC 25868)cells at the C50 concentration was determined.1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID1755808Antibacterial activity against Staphylococcus aureus ATCC 6538 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID166713Tested for binding affinity against RNA construct B2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.
AID757813Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID1265799Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID372898Antibacterial activity against sPseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID207419Minimum inhibitory concentration was measured against Staphylococcus aureus ATCC 259231991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1265817Antifungal activity against azole-resistant Candida albicans ATCC 90819 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1265807Activity of Mycobacterium tuberculosis AAC(2')-1c assessed as compound conversion to monoacetylated product incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1123057Antibacterial activity against kanamycin A/B impermeable Pseudomonas aeruginosa 21509 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID550128Antibacterial activity against Staphylococcus aureus ATCC 29213 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1629123Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1550799Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth incubated for 24 hrs by TTC double broth dilution method
AID493655Antimicrobial activity against Streptococcus faecalis ATCC 9790 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID1265794Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID94373Minimum inhibitory concentration measured against Klebsiella pneumoniae (ATCC 13883)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID166717Tested for binding affinity against RNA construct D2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.
AID1265862Cytotoxicity against human BEAS2B cells after 24 hrs by resazurin assay2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
AID1413299Antibacterial activity against Klebsiella pneumoniae ATCC 138883 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1241202Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1629122Antimicrobial activity against Pseudomonas aeruginosa ATCC 47085 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1054743Antibacterial activity against Staphylococcus aureus ATCC 6538 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID1629125Antimicrobial activity against Haemophilus influenzae ATCC 10211 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1123045Antibacterial activity against Escherichia coli 20665 expressing aminoglycoside-3'-phosphotransferase-1 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID40797Minimum inhibitory concentration measured against Bacillus subtilis (ATCC 6633)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID609864Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
AID1123046Antibacterial activity against Escherichia coli 20732 expressing aminoglycoside-2''-nucleotidyltransferase assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID1629127Antimicrobial activity against Klebsiella pneumoniae ATCC 10031 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1629129Antimicrobial activity against Acinetobacter baumannii ATCC 19606 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1629128Antimicrobial activity against Escherichia coli ATCC 25922 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1265792Antibacterial activity against Staphylococcus aureus NRS385 (USA 300) by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID466789Antibacterial activity against Staphylococcus aureus ATCC 65382010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID550134Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID550135Antibacterial activity against Enterococcus faecalis ATCC 29212 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1265818Antifungal activity against azole-susceptible Candida albicans ATCC MYA-2310 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1241206Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID50557Minimum inhibitory concentration measured against Citrobacter freundii (ATCC 8090)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1577251Antibacterial activity against Pseudomonas aeruginosa MTCC1688 by broth microdilution assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.
AID166719Tested for binding affinity against RNA construct E2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.
AID1061843Toxicity in human erythrocytes assessed as hemolytic activity by spectrophotometric analysis2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID1265796Antibacterial activity against Acinetobacter baumannii ATCC 19606 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1061844Inhibition of Escherichia coli FabH overexpressed in Escherichia coli DH10B cells assessed as incorporation of [3H] in the product after 25 mins by liquid scintillation counting analysis2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID1123047Antibacterial activity against Escherichia coli 21218 expressing aminoglycoside-6'-acetyltransferase assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID70617Minimum inhibitory concentration was measured against Escherichia coli ATCC 25992.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1754629Antibacterial activity against methicillin-sensitive Staphylococcus aureus incubated for 6 to 8 hrs by MABA
AID609866Antibacterial activity against Bacillus subtilis after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
AID236835Maximum Frel value for binding to 3'-Fl-AM1A-Rhd in Bacillus subtilis tyr2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.
AID522933Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a D268N mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID550133Antibacterial activity against Klebsiella pneumoniae ATCC 700603 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1232107Antimicrobial activity against Fusarium graminearum B4-5A using potato dextrose broth as growth medium and diluent2014MedChemComm, Aug-01, Volume: 5, Issue:8
Antifungal Amphiphilic Aminoglycosides.
AID1265810Activity of Mycobacterium tuberculosis AAC(2')-1c/Serratia marcescens AAC(6')-2d assessed as compound conversion to 6'-monoacetylated product incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1076538Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID1123052Antibacterial activity against Proteus rettgeri 21207 expressing aminoglycoside-2'-acetyltransferase assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID513836Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as tRNA translocation rate (Rvb= 1.57+/-0.05 /sec)2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID67859Minimum inhibitory concentration measured against Enterobacter aerogenes (ATCC 13048)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1241205Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID670731Antibacterial activity against Bacillus subtilis ATCC 530 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID550130Antibacterial activity against Staphylococcus epidermidis ATCC 12228 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1265785Antibacterial activity against Bacillus subtilis 168 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1413304Antifungal activity against Fusarium graminearum by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID66237Minimum inhibitory concentration measured against Enterobacter cloacae (ATCC 23355)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1123049Antibacterial activity against Enterobacter cloacae 20364 expressing aminoglycoside-3'-phosphotransferase-1 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID1413296Antibacterial activity against Staphylococcus aureus ATCC 25923 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1061845Antimicrobial activity against Bacillus amyloliquefaciens 23842 assessed as parasite growth inhibition after 24 hrs by two-fold serial broth dilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID1054744Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID255500Minimum inhibitory concentration against Staphylococcus aureus (ATCC 25923)2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Glycodiversification for the optimization of the kanamycin class aminoglycosides.
AID493653Antimicrobial activity against Bacillus subtilis ATCC 6633 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID1061847Antimicrobial activity against Staphylococcus aureus ATCC 25923 assessed as parasite growth inhibition after 24 hrs by two-fold serial broth dilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID255493Minimum inhibitory concentration against Escherichia coli (ATCC 25922)2005Journal of medicinal chemistry, Oct-06, Volume: 48, Issue:20
Glycodiversification for the optimization of the kanamycin class aminoglycosides.
AID1123042Antibacterial activity against Staphylococcus aureus 9537 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID523066Antibacterial activity against Escherichia coli JM83 harboring empty pHF022 vector by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID1061842Cytotoxicity against mouse NIH/3T3 cells after 24 hrs by MTT assay2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID550132Antibacterial activity against Staphylococcus epidermidis 07-9 clinical isolate expressing APH(30)-IIIa after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1129597Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID437462Antimicrobial activity Escherichia coli ATCC 35218 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID1413303Antifungal activity against Saccharomyces cerevisiae W303 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1241211Binding affinity to 5'-FAM-pre-miR-373 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID163260Minimum inhibitory concentration measured against Pseudomonas aeruginosa (NCTC 10701)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1629134Inhibition of cytosolic eukaryotic translation in rabbit reticulocyte S30 extract measured after 60 mins by coupled transcription/translation-based luciferase reporter gene assay2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID450977Antibacterial activity against Staphylococcus aureus after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
AID437461Antimicrobial activity Streptococcus faecalis ATCC 9790 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID1265855Antifungal activity against azole-resistant Candida albicans ATCC 64124 assessed as cell membrane permeabilization at 62.5 ug/ml after 1 hr by propidium iodide-staining based fluorescence microscopic analysis (Rvb = <2%)2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1413295Antibacterial activity against Escherichia coli TG1 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1265815Antifungal activity against azole-resistant Candida albicans ATCC 64124 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1123055Antibacterial activity against Pseudomonas aeruginosa 20653 expressing aminoglycoside-3'-phosphotransferase-4 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID203310Minimum inhibitory concentration was measured against Serratia marcescens ATCC 81001991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID69637Minimum inhibitory concentration measured against Escherichia coli (ATCC 25922)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID609500Antibacterial activity against Pseudomonas fluorescens after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID1265793Antibacterial activity against Staphylococcus aureus NRS22 (USA 600) by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1123048Antibacterial activity against Enterobacter cloacae 9656 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID1419520Induction of membrane permeabilization in Candida albicans ATCC 64121 at 7.8 ug/ml incubated for 1 hr by propidium iodide staining based fluorescence microscopy2017European journal of medicinal chemistry, Jun-16, Volume: 133Novel alkylated azoles as potent antifungals.
AID1241207Inhibition of pre-miR-373 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID436378Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID1123050Antibacterial activity against Klebsiella pneumoniae 9977 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID1577248Antibacterial activity against Staphylococcus epidermidis MTCC3615 by broth microdilution assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.
AID94226Minimum inhibitory concentration was measured against Klebsiella pneumoniae ATCC 138831991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1783237Antimycobacterial activity against Mycobacterium smegmatis ATCC700084 assessed as inhibition of mycobacterial growth by broth microdilution method
AID1629131Antimicrobial activity against aminoglycoside-resistant Escherichia coli ATCC BAA-2452 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID617971Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID199517Compound was tested for the inhibition of Rev-RBE RNA complex formation1998Journal of medicinal chemistry, Jan-15, Volume: 41, Issue:2
Modeling RNA-ligand interactions: the Rev-binding element RNA-aminoglycoside complex.
AID514827Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as stabilization of classical state occupancy by tRNA by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1061848Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 assessed as parasite growth inhibition after 24 hrs by two-fold serial broth dilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID417434Antibacterial activity against Staphylococcus aureus after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID201751Minimum inhibitory concentration was measured against Serratia marcescens S69.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1265860Hemolytic activity against mouse RBC at 100 to 500 ug/ml after 60 mins2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID437460Antimicrobial activity Staphylococcus aureus ATCC 6538 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID163582Minimum inhibitory concentration measured against Proteus vulgaris (ATCC 13315)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1413302Antifungal activity against Candida albicans by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID617970Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID1265790Antibacterial activity against Staphylococcus aureus NRS382 (USA 100) by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1241201Inhibition of pre-miR-372 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1550800Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth incubated for 24 hrs by TTC double broth dilution method
AID522930Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase R92H/D268N mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID1755805Antibacterial activity against Escherichia coli ATCC 35218 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID757812Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID1265861Cytotoxicity against human A549 cells after 24 hrs by resazurin assay2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1129598Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID1265816Antifungal activity against azole-susceptible Candida albicans ATCC MYA-2876 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1769951Antibacterial activity against methicillin resistant Staphylococcus aureus ATCC 43300 assessed as reduction in microbial growth after 16 to 18 hrs by microbroth dilution method2021European journal of medicinal chemistry, Nov-15, Volume: 224Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
AID1265791Antibacterial activity against Staphylococcus aureus NRS383 (USA 200) by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1129596Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID466787Antibacterial activity against Bacillus subtilis ATCC 66332010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID1629126Antimicrobial activity against Klebsiella pneumoniae ATCC 13883 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID513832Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as classical-state occupancy by tRNA (Rvb= 62.4+/-1.1%)2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1265806Activity of AAC(3)-4 (unknown origin) assessed as compound conversion to monoacetylated product incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID375076Binding affinity to A-site RNA2009Journal of medicinal chemistry, Jun-25, Volume: 52, Issue:12
Design and implementation of an ribonucleic acid (RNA) directed fragment library.
AID1061849Antimicrobial activity against Escherichia coli ATCC 25922 assessed as parasite growth inhibition after 24 hrs by two-fold serial broth dilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID1054742Antibacterial activity against Escherichia coli ATCC 35218 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID514828Binding affinity to Escherichia coli 23S rRNA assessed as stabilization of classical state occupancy by tRNA by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID417436Antibacterial activity against Escherichia coli after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID550127Antibacterial activity against Escherichia coli ATCC 35218 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1413305Antifungal activity against Fusarium oxysporum by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID550131Antibacterial activity against methicillin-resistant isolate Staphylococcus epidermidis 08-18 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID436379Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID1413301Antifungal activity against Rhodotorula pilimanae by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID437463Antimicrobial activity Pseudomonas aeruginosa ATCC 13525 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID514830Stabilization of classical-state occupancy by tRNA in ribosomal pre-translocation complex in Escherichia coli MRE600 expressing 16S A1408G and 23S G2553C rRNA mutant by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1265795Antibacterial activity against vancomycin-resistant Enterococcus by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID437464Antimicrobial activity Enterobacter cloacae ATCC 13047 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID450976Antibacterial activity against Bacillus subtilis after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
AID670729Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID372895Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID1474809Antibacterial activity against Bacillus subtilis NBRC 13719 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID201379Minimum inhibitory concentration was measured against Salmonella Typhimurium ATCC 140281991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID609502Antibacterial activity against Staphylococcus aureus after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID493658Antimicrobial activity against Enterobacter cloacae ATCC 13047 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID514822Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as increase in classical-state occupancy by tRNA at 20 nM to 200 uM by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1629124Antimicrobial activity against Haemophilus influenzae ATCC 49247 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1265797Antibacterial activity against Enterobacter cloacae ATCC 13047 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID522932Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a N196D mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID1265808Activity of Serratia marcescens AAC(6')-2d assessed as compound conversion to monoacetylated product incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1129599Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Apr-09, Volume: 76Design, synthesis and molecular modeling of pyrazole-quinoline-pyridine hybrids as a new class of antimicrobial and anticancer agents.
AID514829Binding affinity to Escherichia coli 16S A1408G rRNA assessed as increase in classical-state occupancy by tRNA by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID372899Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID522929Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase N196D/D268N mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID1241210Binding affinity to 5'-FAM-pre-miR-17 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID40944Minimum inhibitory concentration was measured against Bacillus subtilis ATCC 6633.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID493657Antimicrobial activity against Escherichia coli ATCC 35218 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID466786Antibacterial activity against Escherichia coli ATCC 352182010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID1413297Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1123044Antibacterial activity against Escherichia coli 9632 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID65062Lethal dose required to kill 90% of the Escherichia coli K12 (ATCC 25868) cell population1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID609499Antibacterial activity against Escherichia coli after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID514825Binding affinity to Escherichia coli 23S rRNA G2553C mutant assessed as increase in classical-state occupancy by tRNA by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1629132Antimicrobial activity against aminoglycoside-resistant Klebsiella pneumoniae ATCC BAA-2470 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID1241208Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID372897Antibacterial activity against Streptococcus faecalis ATCC 9790 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID203162Minimum inhibitory concentration measured against Serratia marcescens (ATCC 8100)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1265811Activity of AAC(3)-4 (unknown origin)/Serratia marcescens AAC(6')-2d assessed as compound conversion to 3'-acetylated product incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1265809Activity of Mycobacterium tuberculosis AAC(2')-1c/AAC(3)-4 (unknown origin) assessed as compound conversion to 3'-acetylated product incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1123053Antibacterial activity against Pseudomonas aeruginosa 9843a assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID609501Antibacterial activity against Bacillus subtilis after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID1054741Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 assessed as growth inhibition after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Dec-01, Volume: 23, Issue:23
Schiff's base derivatives bearing nitroimidazole moiety: new class of antibacterial, anticancer agents and potential EGFR tyrosine kinase inhibitors.
AID609867Antibacterial activity against Staphylococcus aureus after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
AID514826Binding affinity to Escherichia coli 23S rRNA assessed as increase in classical-state occupancy by tRNA at 20 uM by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1123043Antibacterial activity against Staphylococcus aureus 20240 expressing aminoglycoside-3'-phosphotransferase-4 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID757810Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID1265789Antibacterial activity against Staphylococcus aureus ATCC 29213 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1265800Antibacterial activity against Salmonella enterica ATCC 14028 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1265812Activity of Mycobacterium tuberculosis AAC(2')-2c/AAC(3)-4 (unknown origin)/Serratia marcescens AAC(6')-2d (unknown origin) assessed as compound conversion to diacetylated adduct incubated for 20 hrs by TLC analysis2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1629130Antimicrobial activity against aminoglycoside-resistant Burkholderia cepacia ATCC 25416 measured after 24 hrs by double-dilution method2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID466788Antibacterial activity against Pseudomonas aeruginosa ATCC 27852010Bioorganic & medicinal chemistry letters, Mar-15, Volume: 20, Issue:6
Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents.
AID609865Antibacterial activity against Pseudomonas fluorescens after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Aug-01, Volume: 19, Issue:15
Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors.
AID1755806Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID203161Minimum inhibitory concentration measured against CDC 87457 strain1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID166711Tested for binding affinity against RNA construct A2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.
AID1510740Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by NCCLS method2019European journal of medicinal chemistry, Oct-01, Volume: 179Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
AID1510737Antibacterial activity against Staphylococcus aureus ATCC 25923 after 24 hrs by NCCLS method2019European journal of medicinal chemistry, Oct-01, Volume: 179Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
AID66097Minimum inhibitory concentration was measured against Enterobacter cloacae ATCC 233551991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1241204Inhibition of pre-miR-21 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID238131Binding dissociation constant towards 3'-Fl-AM1A-Rhd in Bacillus subtilis tyrS2005Bioorganic & medicinal chemistry letters, Apr-15, Volume: 15, Issue:8
Fluorescence resonance energy transfer studies of aminoglycoside binding to a T box antiterminator RNA.
AID1474808Antibacterial activity against Staphylococcus aureus NBRC 100910 after overnight incubation by microdilution method2017Bioorganic & medicinal chemistry letters, 06-01, Volume: 27, Issue:11
Syntheses of benzophenone-xanthone hybrid polyketides and their antibacterial activities.
AID200875Minimum inhibitory concentration measured against Salmonella Typhimurium (ATCC 14028)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1265814Antifungal activity against azole-resistant Candida albicans ATCC 10231 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID450975Antibacterial activity against Pseudomonas fluorescens after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
AID65071Estimated rate of [3H]DHS uptake in Escherichia coli K12 (ATCC 25868)1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID436377Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID1577250Antibacterial activity against Escherichia coli MTCC1916 by broth microdilution assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.
AID550126Antibacterial activity against Escherichia coli ATCC 25922 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID206211Minimum inhibitory concentration measured against Staphylococcus epidermidis (ATCC 12228)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1265788Antibacterial activity against Mycobacterium smegmatis MC2 155 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1755807Antibacterial activity against Bacillus subtilis ATCC 6633 incubated for 24 hrs by two fold serial dilution method2021European journal of medicinal chemistry, Jan-15, Volume: 210Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
AID1265821Antifungal activity against Aspergillus nidulans ATCC 38163 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID514831Binding affinity to Escherichia coli 23S rRNA G2553C mutant assessed as increase in classical-state occupancy by tRNA at 20 uM by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID1241209Binding affinity to 5'-FAM-pre-miR-372 (unknown origin) after 4 hrs by fluorescence assay2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID2940Binding affinity of aminoglycoside to 16S ribosomal RNA A-site in Escherichia coli2001Bioorganic & medicinal chemistry letters, Jan-22, Volume: 11, Issue:2
Which aminoglycoside ring is most important for binding? A hydropathic analysis of gentamicin, paromomycin, and analogues.
AID417433Antibacterial activity against Bacillus subtilis after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID644960Displacement of ethidium bromide from human pre-hsa-mir-155 miRNA after 30 mins2012Bioorganic & medicinal chemistry letters, Feb-15, Volume: 22, Issue:4
Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
AID1265820Antifungal activity against azole-resistant Candida albicans MYA-1003 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID617969Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID1076539Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID493654Antimicrobial activity against Staphylococcus aureus ATCC 6538 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID514823Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as increase in classical-state occupancy by tRNA at >=20 uM by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID166716Tested for binding affinity against RNA construct C; n.b. means no observable binding2002Bioorganic & medicinal chemistry letters, Feb-11, Volume: 12, Issue:3
Binding of aminoglycoside antibiotics with modified A-site 16S rRNA construct containing non-nucleotide linkers.
AID1265786Antibacterial activity against Listeria monocytogenes ATCC 19115 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1061846Antimicrobial activity against Bacillus subtilis ATCC 530 assessed as parasite growth inhibition after 24 hrs by two-fold serial broth dilution method2014Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1
Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
AID1241203Inhibition of pre-miR-17 (unknown origin) cleavage assessed as reduction of oncogenic microRNAs biogenesis at 200 uM by measuring fluorescence every minute for 5 hrs using 5'-FAM,3'-dabcyl-pre-miRNA beacons by FRET assay in presence of recombinant Dicer2015Bioorganic & medicinal chemistry, Sep-01, Volume: 23, Issue:17
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
AID1754628Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 6548 incubated for 6 to 8 hrs by MABA
AID493656Antimicrobial activity against Pseudomonas aeruginosa ATCC 13525 by MTT assay2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
AID550129Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1265819Antifungal activity against azole-resistant Candida albicans MYA-1237 after 48 hrs by microbroth dilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1413300Antibacterial activity against Klebsiella pneumoniae ATCC 700603 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1550801Antibacterial activity against Bacillus subtilis ATCC 530 assessed as inhibition of bacterial growth incubated for 24 hrs by TTC double broth dilution method
AID522928Antibacterial activity against Escherichia coli JM83 producing aminoglycoside 2''-2a phosphotransferase by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID1629133Binding affinity to 16S rRNA A-site in Escherichia coli S30 extract assessed as inhibition of translation measured after 30 mins by coupled transcription/translation-based luciferase reporter gene assay2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID550136Antibacterial activity against Escherichia coli BL21 expressing pET29a engineering strain expressing APH(30)-Ia after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1265798Antibacterial activity against Escherichia coli MC1061 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID102990In vitro inhibitory activity against Lysosomal phospholipase A1 consisting of negatively charged liposomes and lysosomal extracts.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID417435Antibacterial activity against Pseudomonas fluorescens after 24 hrs by MTT method2009European journal of medicinal chemistry, Feb, Volume: 44, Issue:2
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
AID1754630Antibacterial activity against vancomycin-resistant Enterococcus faecium incubated for 6 to 8 hrs by MABA
AID151666Minimum inhibitory concentration was measured against Pseudomonas aeruginosa ATCC 278531991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1577247Antibacterial activity against Staphylococcus aureus MTCC737 measured after 6 hrs by broth microdilution assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.
AID757811Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2013Bioorganic & medicinal chemistry letters, Jul-15, Volume: 23, Issue:14
Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
AID437459Antimicrobial activity Bacillus subtilis ATCC 6633 by MTT assay2009Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
AID617968Antibacterial activity against Escherichia coli ATCC 35218 after 24 hrs by MTT assay2011Bioorganic & medicinal chemistry, Sep-15, Volume: 19, Issue:18
Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
AID1577249Antibacterial activity against Arthrobacter chlorophenolicus A6MTCC3706 by broth microdilution assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.
AID450974Antibacterial activity against Escherichia coli after 24 hrs by MTT assay2009Bioorganic & medicinal chemistry, Sep-01, Volume: 17, Issue:17
Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
AID65059Concentration required for half maximum rate of enhanced [3H]DHS uptake in Escherichia coli K121987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
Comparison of aminoglycoside antibiotics with respect to uptake and lethal activity in Escherichia coli.
AID1577252Cytotoxicity against HEK293 cells measured after 24 hrs by MTT assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
DNA Structural Alteration Leading to Antibacterial Properties of 6-Nitroquinoxaline Derivatives.
AID436380Antibacterial activity against Pseudomonas aeruginosa ATCC 13525 after 24 hrs by MTT method2009European journal of medicinal chemistry, Oct, Volume: 44, Issue:10
Synthesis, structure and structure-activity relationship analysis of 3-tert-butoxycarbonyl-2-arylthiazolidine-4-carboxylic acid derivatives as potential antibacterial agents.
AID206371Minimum inhibitory concentration measured against Staphylococcus faecalis (ATCC 19431)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID372900Antibacterial activity against Enterobacter cloacae ATCC 13047 after 24 hrs by MTT assay2009European journal of medicinal chemistry, Apr, Volume: 44, Issue:4
Synthesis, characterization and structure-activity relationship analysis of novel depsides as potential antibacterials.
AID550137Antibacterial activity against Mortierella alpina ATCC 32221 after 16-20 hrs by microdilution broth method2011Bioorganic & medicinal chemistry, Jan-01, Volume: 19, Issue:1
Rational design and synthesis of potent aminoglycoside antibiotics against resistant bacterial strains.
AID1076536Antibacterial activity against Staphylococcus aureus ATCC 6538 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID514824Binding affinity to Escherichia coli 16S rRNA helix 44 assessed as increase in classical-state occupancy by tRNA by smFRET2010Nature chemical biology, Jan, Volume: 6, Issue:1
Aminoglycoside activity observed on single pre-translocation ribosome complexes.
AID206208Minimum inhibitory concentration was measured against Staphylococcus epidermidis ATCC 12228.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID1123051Antibacterial activity against Proteus rettgeri 9637 assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID201750Minimum inhibitory concentration was measured against Serratia marcescens S20.1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by combined modifications in positions 1 and 6". Synthesis, microbiological properties, and in vitro and computer-aided toxicological evaluation.
AID522931Antibacterial activity against Escherichia coli JM83 harboring pHF022 containing aminoglycoside 2''-2a phosphotransferase R92H mutant by broth microdilution method2010Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
AID1510739Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by NCCLS method2019European journal of medicinal chemistry, Oct-01, Volume: 179Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
AID1629135Selectivity ratio, ratio of IC50 for cytosolic eukaryotic translation in rabbit reticulocyte S30 extract to IC50 for 16S rRNA A-site in Escherichia coli S30 extract2016Journal of medicinal chemistry, 09-08, Volume: 59, Issue:17
Effects of 5-O-Ribosylation of Aminoglycosides on Antimicrobial Activity and Selective Perturbation of Bacterial Translation.
AID207856Minimum inhibitory concentration measured against Staphylococcus aureus (ATCC 25923)1991Journal of medicinal chemistry, Apr, Volume: 34, Issue:4
New derivatives of kanamycin B obtained by modifications and substitutions in position 6". 1. Synthesis and microbiological evaluation.
AID1754631Antibacterial activity against vancomycin-sensitive Enterococcus faecium incubated for 6 to 8 hrs by MABA
AID1510738Antibacterial activity against Bacillus subtilis ATCC 530 after 24 hrs by NCCLS method2019European journal of medicinal chemistry, Oct-01, Volume: 179Nitroimidazole-containing compounds and their antibacterial and antitubercular activities.
AID1265782Antibacterial activity against Klebsiella pneumoniae ATCC 27736 by microdilution method2015Journal of medicinal chemistry, Dec-10, Volume: 58, Issue:23
Synthesis and Bioactivities of Kanamycin B-Derived Cationic Amphiphiles.
AID1076537Antibacterial activity against Bacillus subtilis ATCC 6633 after 24 hrs by MTT assay2014European journal of medicinal chemistry, Mar-21, Volume: 75Design and synthesis of thiazole derivatives as potent FabH inhibitors with antibacterial activity.
AID670728Antibacterial activity against Escherichia coli ATCC 25922 after 24 hrs by MTT assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
AID1123056Antibacterial activity against Pseudomonas aeruginosa 20897 expressing aminoglycoside-3'-phosphotransferase-1 and aminoglycoside-6'-acetyltransferase assessed as growth inhibition measured after overnight incubation by two-fold broth dilution method1979Journal of medicinal chemistry, Apr, Volume: 22, Issue:4
Aminoglycoside antibiotics. 2. N,N-Dialkylkanamycins.
AID1413298Antibacterial activity against Enterococcus faecalis ATCC 29212 by microbroth dilution assay2018MedChemComm, Jun-01, Volume: 9, Issue:6
Antifungal amphiphilic kanamycins: new life for an old drug.
AID1550802Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as inhibition of bacterial growth incubated for 24 hrs by TTC double broth dilution method
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (109)

TimeframeStudies, This Drug (%)All Drugs %
pre-199021 (19.27)18.7374
1990's14 (12.84)18.2507
2000's24 (22.02)29.6817
2010's42 (38.53)24.3611
2020's8 (7.34)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.19 (24.57)
Research Supply Index4.81 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (3.39%)5.53%
Reviews4 (3.39%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other110 (93.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]